Sodium chloride/dextran 70
Alternative Names: Hypertonic saline dextran; RescueFlow; Sodium chloride/dextranLatest Information Update: 21 Dec 2016
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Developer Karo Pharma AB; Medisan Pharmaceuticals AB; Nonindustrial source
- Class Electrolytes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypovolaemia
Most Recent Events
- 07 Jun 2011 BioPhausia has been acquired by Medivir AB
- 15 May 2007 Launched for Hypovolaemia in France (IV)
- 15 May 2004 Launched for Hypovolaemia in Israel (IV)